Voriconazole	B:C0393080
metabolism	O
is	O
influenced	O
by	O
severe	O
inflammation	O
:	O
a	O
prospective	O
study	I:C0033522
.	O

Voriconazole	O
metabolism	B:C0683140
is	O
influenced	O
by	O
severe	O
inflammation	O
:	O
a	O
prospective	O
study	I:C0033522
.	O

Voriconazole	O
metabolism	O
is	O
influenced	O
by	O
severe	O
inflammation	B:C0021368
:	O
a	O
prospective	O
study	I:C0033522
.	O

Voriconazole	O
metabolism	O
is	O
influenced	O
by	O
severe	O
inflammation	O
:	O
a	O
prospective	B:C0033522
study	I:C0033522
.	O

During	O
an	O
infection	B:C3714514
or	O
inflammation	O
,	O
several	O
drug	O
-	O
metabolizing	O
enzymes	O
in	O
the	O
liver	O
are	O
down	O
-	I:C1327624
regulated	I:C1327624
,	O
including	O
cytochrome	O
P450	I:C0010762
iso	I:C0010762
-	I:C0010762
enzymes	I:C0010762
.	O

During	O
an	O
infection	O
or	O
inflammation	B:C0021368
,	O
several	O
drug	O
-	O
metabolizing	O
enzymes	O
in	O
the	O
liver	O
are	O
down	O
-	I:C1327624
regulated	I:C1327624
,	O
including	O
cytochrome	O
P450	I:C0010762
iso	I:C0010762
-	I:C0010762
enzymes	I:C0010762
.	O

During	O
an	O
infection	O
or	O
inflammation	O
,	O
several	O
drug	B:C1254351
-	O
metabolizing	O
enzymes	O
in	O
the	O
liver	O
are	O
down	O
-	I:C1327624
regulated	I:C1327624
,	O
including	O
cytochrome	O
P450	I:C0010762
iso	I:C0010762
-	I:C0010762
enzymes	I:C0010762
.	O

During	O
an	O
infection	O
or	O
inflammation	O
,	O
several	O
drug	O
-	O
metabolizing	B:C0683140
enzymes	O
in	O
the	O
liver	O
are	O
down	O
-	I:C1327624
regulated	I:C1327624
,	O
including	O
cytochrome	O
P450	I:C0010762
iso	I:C0010762
-	I:C0010762
enzymes	I:C0010762
.	O

During	O
an	O
infection	O
or	O
inflammation	O
,	O
several	O
drug	O
-	O
metabolizing	O
enzymes	B:C0014442
in	O
the	O
liver	O
are	O
down	O
-	I:C1327624
regulated	I:C1327624
,	O
including	O
cytochrome	O
P450	I:C0010762
iso	I:C0010762
-	I:C0010762
enzymes	I:C0010762
.	O

During	O
an	O
infection	O
or	O
inflammation	O
,	O
several	O
drug	O
-	O
metabolizing	O
enzymes	O
in	O
the	O
liver	B:C0023884
are	O
down	O
-	I:C1327624
regulated	I:C1327624
,	O
including	O
cytochrome	O
P450	I:C0010762
iso	I:C0010762
-	I:C0010762
enzymes	I:C0010762
.	O

During	O
an	O
infection	O
or	O
inflammation	O
,	O
several	O
drug	O
-	O
metabolizing	O
enzymes	O
in	O
the	O
liver	O
are	O
down	B:C1327624
-	I:C1327624
regulated	I:C1327624
,	O
including	O
cytochrome	O
P450	I:C0010762
iso	I:C0010762
-	I:C0010762
enzymes	I:C0010762
.	O

During	O
an	O
infection	O
or	O
inflammation	O
,	O
several	O
drug	O
-	O
metabolizing	O
enzymes	O
in	O
the	O
liver	O
are	O
down	O
-	I:C1327624
regulated	I:C1327624
,	O
including	O
cytochrome	B:C0010762
P450	I:C0010762
iso	I:C0010762
-	I:C0010762
enzymes	I:C0010762
.	O

Since	O
voriconazole	B:C0393080
is	O
extensively	O
metabolized	O
by	O
cytochrome	O
P450	I:C0010762
iso	I:C0010762
-	I:C0010762
enzymes	I:C0010762
,	O
the	O
metabolism	O
of	O
voriconazole	O
can	O
be	O
influenced	O
during	O
inflammation	O
via	O
reduced	O
clearance	O
of	I:C0683151
the	I:C0683151
drug	I:C0683151
,	O
resulting	O
in	O
higher	O
voriconazole	O
trough	O
concentrations	O
.	O

Since	O
voriconazole	O
is	O
extensively	O
metabolized	B:C0683140
by	O
cytochrome	O
P450	I:C0010762
iso	I:C0010762
-	I:C0010762
enzymes	I:C0010762
,	O
the	O
metabolism	O
of	O
voriconazole	O
can	O
be	O
influenced	O
during	O
inflammation	O
via	O
reduced	O
clearance	O
of	I:C0683151
the	I:C0683151
drug	I:C0683151
,	O
resulting	O
in	O
higher	O
voriconazole	O
trough	O
concentrations	O
.	O

Since	O
voriconazole	O
is	O
extensively	O
metabolized	O
by	O
cytochrome	B:C0010762
P450	I:C0010762
iso	I:C0010762
-	I:C0010762
enzymes	I:C0010762
,	O
the	O
metabolism	O
of	O
voriconazole	O
can	O
be	O
influenced	O
during	O
inflammation	O
via	O
reduced	O
clearance	O
of	I:C0683151
the	I:C0683151
drug	I:C0683151
,	O
resulting	O
in	O
higher	O
voriconazole	O
trough	O
concentrations	O
.	O

Since	O
voriconazole	O
is	O
extensively	O
metabolized	O
by	O
cytochrome	O
P450	I:C0010762
iso	I:C0010762
-	I:C0010762
enzymes	I:C0010762
,	O
the	O
metabolism	B:C0683140
of	O
voriconazole	O
can	O
be	O
influenced	O
during	O
inflammation	O
via	O
reduced	O
clearance	O
of	I:C0683151
the	I:C0683151
drug	I:C0683151
,	O
resulting	O
in	O
higher	O
voriconazole	O
trough	O
concentrations	O
.	O

Since	O
voriconazole	O
is	O
extensively	O
metabolized	O
by	O
cytochrome	O
P450	I:C0010762
iso	I:C0010762
-	I:C0010762
enzymes	I:C0010762
,	O
the	O
metabolism	O
of	O
voriconazole	B:C0393080
can	O
be	O
influenced	O
during	O
inflammation	O
via	O
reduced	O
clearance	O
of	I:C0683151
the	I:C0683151
drug	I:C0683151
,	O
resulting	O
in	O
higher	O
voriconazole	O
trough	O
concentrations	O
.	O

Since	O
voriconazole	O
is	O
extensively	O
metabolized	O
by	O
cytochrome	O
P450	I:C0010762
iso	I:C0010762
-	I:C0010762
enzymes	I:C0010762
,	O
the	O
metabolism	O
of	O
voriconazole	O
can	O
be	O
influenced	O
during	O
inflammation	B:C0021368
via	O
reduced	O
clearance	O
of	I:C0683151
the	I:C0683151
drug	I:C0683151
,	O
resulting	O
in	O
higher	O
voriconazole	O
trough	O
concentrations	O
.	O

Since	O
voriconazole	O
is	O
extensively	O
metabolized	O
by	O
cytochrome	O
P450	I:C0010762
iso	I:C0010762
-	I:C0010762
enzymes	I:C0010762
,	O
the	O
metabolism	O
of	O
voriconazole	O
can	O
be	O
influenced	O
during	O
inflammation	O
via	O
reduced	O
clearance	B:C0683151
of	I:C0683151
the	I:C0683151
drug	I:C0683151
,	O
resulting	O
in	O
higher	O
voriconazole	O
trough	O
concentrations	O
.	O

Since	O
voriconazole	O
is	O
extensively	O
metabolized	O
by	O
cytochrome	O
P450	I:C0010762
iso	I:C0010762
-	I:C0010762
enzymes	I:C0010762
,	O
the	O
metabolism	O
of	O
voriconazole	O
can	O
be	O
influenced	O
during	O
inflammation	O
via	O
reduced	O
clearance	O
of	I:C0683151
the	I:C0683151
drug	I:C0683151
,	O
resulting	O
in	O
higher	O
voriconazole	B:C0393080
trough	O
concentrations	O
.	O

To	O
investigate	O
prospectively	O
the	O
influence	O
of	O
inflammation	B:C0021368
on	O
voriconazole	O
metabolism	O
and	O
voriconazole	O
trough	O
concent	O
ratio	O
ns	O
.	O

To	O
investigate	O
prospectively	O
the	O
influence	O
of	O
inflammation	O
on	O
voriconazole	B:C0393080
metabolism	O
and	O
voriconazole	O
trough	O
concent	O
ratio	O
ns	O
.	O

To	O
investigate	O
prospectively	O
the	O
influence	O
of	O
inflammation	O
on	O
voriconazole	O
metabolism	B:C0683140
and	O
voriconazole	O
trough	O
concent	O
ratio	O
ns	O
.	O

To	O
investigate	O
prospectively	O
the	O
influence	O
of	O
inflammation	O
on	O
voriconazole	O
metabolism	O
and	O
voriconazole	B:C0393080
trough	O
concent	O
ratio	O
ns	O
.	O

A	O
prospective	B:C0033522
observational	I:C0033522
study	I:C0033522
was	O
performed	O
at	O
the	O
University	O
Medical	I:C0000872
Center	I:C0000872
Groningen	O
.	O

A	O
prospective	O
observational	I:C0033522
study	I:C0033522
was	O
performed	O
at	O
the	O
University	B:C0000872
Medical	I:C0000872
Center	I:C0000872
Groningen	O
.	O

A	O
prospective	O
observational	I:C0033522
study	I:C0033522
was	O
performed	O
at	O
the	O
University	O
Medical	I:C0000872
Center	I:C0000872
Groningen	B:C0017446
.	O

Patients	O
were	O
eligible	O
for	O
inclusion	O
if	O
they	O
were	O
≥	O
18	O
years	O
old	O
and	O
treated	B:C0332293
with	I:C0332293
voriconazole	O
.	O

Patients	O
were	O
eligible	O
for	O
inclusion	O
if	O
they	O
were	O
≥	O
18	O
years	O
old	O
and	O
treated	O
with	I:C0332293
voriconazole	B:C0393080
.	O

Voriconazole	B:C0393080
and	O
voriconazole	O
-	O
N	O
-	O
oxide	O
concentrations	O
were	O
determined	O
in	O
discarded	O
blood	O
samples	I:C0178913
.	O

Voriconazole	O
and	O
voriconazole	O
-	O
N	O
-	O
oxide	O
concentrations	O
were	O
determined	O
in	O
discarded	O
blood	B:C0178913
samples	I:C0178913
.	O

To	O
determine	O
the	O
degree	O
of	O
inflammation	B:C0021368
,	O
C	O
-	I:C0201657
reactive	I:C0201657
protein	I:C0201657
(	I:C0201657
CRP	I:C0201657
)	I:C0201657
concentrations	I:C0201657
were	O
used	O
.	O

To	O
determine	O
the	O
degree	O
of	O
inflammation	O
,	O
C	B:C0201657
-	I:C0201657
reactive	I:C0201657
protein	I:C0201657
(	I:C0201657
CRP	I:C0201657
)	I:C0201657
concentrations	I:C0201657
were	O
used	O
.	O

Subsequently	O
,	O
a	O
longitudinal	B:C0023981
data	I:C0023981
analysis	I:C0023981
was	O
performed	O
to	O
assess	O
the	O
effect	O
of	O
inflammation	O
on	O
the	O
metabolic	O
ratio	O
and	O
voriconazole	O
trough	O
concentration	O
.	O

Subsequently	O
,	O
a	O
longitudinal	O
data	I:C0023981
analysis	I:C0023981
was	O
performed	O
to	O
assess	O
the	O
effect	O
of	O
inflammation	B:C0021368
on	O
the	O
metabolic	O
ratio	O
and	O
voriconazole	O
trough	O
concentration	O
.	O

Subsequently	O
,	O
a	O
longitudinal	O
data	I:C0023981
analysis	I:C0023981
was	O
performed	O
to	O
assess	O
the	O
effect	O
of	O
inflammation	O
on	O
the	O
metabolic	B:C0683140
ratio	O
and	O
voriconazole	O
trough	O
concentration	O
.	O

Subsequently	O
,	O
a	O
longitudinal	O
data	I:C0023981
analysis	I:C0023981
was	O
performed	O
to	O
assess	O
the	O
effect	O
of	O
inflammation	O
on	O
the	O
metabolic	O
ratio	O
and	O
voriconazole	B:C0393080
trough	O
concentration	O
.	O

In	O
total	O
489	O
voriconazole	B:C0393080
trough	O
concentrations	O
were	O
included	O
in	O
the	O
longitudinal	O
data	I:C0023981
analysis	I:C0023981
.	O

In	O
total	O
489	O
voriconazole	O
trough	O
concentrations	O
were	O
included	O
in	O
the	O
longitudinal	B:C0023981
data	I:C0023981
analysis	I:C0023981
.	O

This	O
analysis	B:C0023981
showed	O
that	O
inflammation	O
,	O
reflected	O
by	O
CRP	O
concentrations	I:C0201657
,	O
significantly	O
influence	O
d	O
the	O
metabolic	O
ratio	O
,	O
voriconazole	O
trough	O
concentration	O
and	O
voriconazole	O
-	O
N	O
-	O
oxide	O
concentration	O
(	O
all	O
P	O
<	O
0.001	O
)	O
,	O
when	O
corrected	O
for	O
other	O
factors	O
that	O
could	O
influence	O
voriconazole	O
metabolism	O
.	O

This	O
analysis	O
showed	O
that	O
inflammation	B:C0021368
,	O
reflected	O
by	O
CRP	O
concentrations	I:C0201657
,	O
significantly	O
influence	O
d	O
the	O
metabolic	O
ratio	O
,	O
voriconazole	O
trough	O
concentration	O
and	O
voriconazole	O
-	O
N	O
-	O
oxide	O
concentration	O
(	O
all	O
P	O
<	O
0.001	O
)	O
,	O
when	O
corrected	O
for	O
other	O
factors	O
that	O
could	O
influence	O
voriconazole	O
metabolism	O
.	O

This	O
analysis	O
showed	O
that	O
inflammation	O
,	O
reflected	O
by	O
CRP	B:C0201657
concentrations	I:C0201657
,	O
significantly	O
influence	O
d	O
the	O
metabolic	O
ratio	O
,	O
voriconazole	O
trough	O
concentration	O
and	O
voriconazole	O
-	O
N	O
-	O
oxide	O
concentration	O
(	O
all	O
P	O
<	O
0.001	O
)	O
,	O
when	O
corrected	O
for	O
other	O
factors	O
that	O
could	O
influence	O
voriconazole	O
metabolism	O
.	O

This	O
analysis	O
showed	O
that	O
inflammation	O
,	O
reflected	O
by	O
CRP	O
concentrations	I:C0201657
,	O
significantly	O
influence	O
d	O
the	O
metabolic	B:C0683140
ratio	O
,	O
voriconazole	O
trough	O
concentration	O
and	O
voriconazole	O
-	O
N	O
-	O
oxide	O
concentration	O
(	O
all	O
P	O
<	O
0.001	O
)	O
,	O
when	O
corrected	O
for	O
other	O
factors	O
that	O
could	O
influence	O
voriconazole	O
metabolism	O
.	O

This	O
analysis	O
showed	O
that	O
inflammation	O
,	O
reflected	O
by	O
CRP	O
concentrations	I:C0201657
,	O
significantly	O
influence	O
d	O
the	O
metabolic	O
ratio	O
,	O
voriconazole	B:C0393080
trough	O
concentration	O
and	O
voriconazole	O
-	O
N	O
-	O
oxide	O
concentration	O
(	O
all	O
P	O
<	O
0.001	O
)	O
,	O
when	O
corrected	O
for	O
other	O
factors	O
that	O
could	O
influence	O
voriconazole	O
metabolism	O
.	O

This	O
analysis	O
showed	O
that	O
inflammation	O
,	O
reflected	O
by	O
CRP	O
concentrations	I:C0201657
,	O
significantly	O
influence	O
d	O
the	O
metabolic	O
ratio	O
,	O
voriconazole	O
trough	O
concentration	O
and	O
voriconazole	O
-	O
N	O
-	O
oxide	O
concentration	O
(	O
all	O
P	O
<	O
0.001	O
)	O
,	O
when	O
corrected	O
for	O
other	O
factors	O
that	O
could	O
influence	O
voriconazole	B:C0393080
metabolism	O
.	O

This	O
analysis	O
showed	O
that	O
inflammation	O
,	O
reflected	O
by	O
CRP	O
concentrations	I:C0201657
,	O
significantly	O
influence	O
d	O
the	O
metabolic	O
ratio	O
,	O
voriconazole	O
trough	O
concentration	O
and	O
voriconazole	O
-	O
N	O
-	O
oxide	O
concentration	O
(	O
all	O
P	O
<	O
0.001	O
)	O
,	O
when	O
corrected	O
for	O
other	O
factors	O
that	O
could	O
influence	O
voriconazole	O
metabolism	B:C0683140
.	O

The	O
metabolic	B:C0683140
ratio	O
was	O
decreased	O
by	O
0.99229	O
(	O
N	O
)	O
and	O
the	O
voriconazole	O
-	O
N	O
-	O
oxide	O
concentration	O
by	O
0.99775	O
(	O
N	O
)	O
,	O
while	O
the	O
voriconazole	O
trough	O
concentration	O
was	O
increased	O
by	O
1.005321	O
(	O
N	O
)	O
,	O
where	O
N	O
is	O
the	O
difference	O
in	O
C	O
-	I:C0006560
reactive	I:C0006560
protein	I:C0006560
units	O
(	O
in	O
mg	O
/	O
L	O
)	O
.	O

The	O
metabolic	O
ratio	O
was	O
decreased	O
by	O
0.99229	O
(	O
N	O
)	O
and	O
the	O
voriconazole	O
-	O
N	O
-	O
oxide	O
concentration	O
by	O
0.99775	O
(	O
N	O
)	O
,	O
while	O
the	O
voriconazole	B:C0393080
trough	O
concentration	O
was	O
increased	O
by	O
1.005321	O
(	O
N	O
)	O
,	O
where	O
N	O
is	O
the	O
difference	O
in	O
C	O
-	I:C0006560
reactive	I:C0006560
protein	I:C0006560
units	O
(	O
in	O
mg	O
/	O
L	O
)	O
.	O

The	O
metabolic	O
ratio	O
was	O
decreased	O
by	O
0.99229	O
(	O
N	O
)	O
and	O
the	O
voriconazole	O
-	O
N	O
-	O
oxide	O
concentration	O
by	O
0.99775	O
(	O
N	O
)	O
,	O
while	O
the	O
voriconazole	O
trough	O
concentration	O
was	O
increased	O
by	O
1.005321	O
(	O
N	O
)	O
,	O
where	O
N	O
is	O
the	O
difference	O
in	O
C	B:C0006560
-	I:C0006560
reactive	I:C0006560
protein	I:C0006560
units	O
(	O
in	O
mg	O
/	O
L	O
)	O
.	O

This	O
study	O
shows	O
that	O
voriconazole	B:C0393080
metabolism	O
is	O
decreased	O
during	O
inflammation	O
,	O
resulting	O
in	O
higher	O
voriconazole	O
trough	O
concentration	O
s.	O

This	O
study	O
shows	O
that	O
voriconazole	O
metabolism	B:C0683140
is	O
decreased	O
during	O
inflammation	O
,	O
resulting	O
in	O
higher	O
voriconazole	O
trough	O
concentration	O
s.	O

This	O
study	O
shows	O
that	O
voriconazole	O
metabolism	O
is	O
decreased	O
during	O
inflammation	B:C0021368
,	O
resulting	O
in	O
higher	O
voriconazole	O
trough	O
concentration	O
s.	O

This	O
study	O
shows	O
that	O
voriconazole	O
metabolism	O
is	O
decreased	O
during	O
inflammation	O
,	O
resulting	O
in	O
higher	O
voriconazole	B:C0393080
trough	O
concentration	O
s.	O

Therefore	O
,	O
frequent	O
monitoring	B:C1283169
of	O
voriconazole	O
serum	O
concentrations	O
is	O
recommended	O
during	O
and	O
following	O
severe	O
inflammation	O
.	O

Therefore	O
,	O
frequent	O
monitoring	O
of	O
voriconazole	B:C0393080
serum	O
concentrations	O
is	O
recommended	O
during	O
and	O
following	O
severe	O
inflammation	O
.	O

Therefore	O
,	O
frequent	O
monitoring	O
of	O
voriconazole	O
serum	O
concentrations	O
is	O
recommended	O
during	O
and	O
following	O
severe	O
inflammation	B:C0021368
.	O

